Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity
Frequency: Administer either once in the evening or twice daily
Pomegranate juice and punicalagin attenuate oxidative stress and apoptosis in human placenta and human placental trophoblasts
"Glucagon regulates lipolysis and fatty acid oxidation through inositol triphosphate receptor 1 in the liver"
Emphasis should be placed on: Increasing consumption of vegetables, fruits, and whole grains Choosing lean protein sources to preserve muscle mass during weight loss Reducing intake of processed foods, sugary beverages, and high-fat items Practising portion control and mindful eating techniques Low-calorie diets (typically 8001200 kcal/day) or very low-calorie diets (VLCDs, usually less than 800 kcal/day, often as total diet replacement products) may be considered for short periods under medical supervision within a multicomponent weight management programme for individuals with a BMI over 30 kg/m, particularly when rapid initial weight loss is clinically beneficial
As opposed to having GLP-1 around all the time, which is what these meds do